Matches in Wikidata for { <http://www.wikidata.org/entity/Q37627010> ?p ?o ?g. }
- Q37627010 description "article científic" @default.
- Q37627010 description "article scientifique" @default.
- Q37627010 description "articolo scientifico" @default.
- Q37627010 description "artigo científico" @default.
- Q37627010 description "artículu científicu espublizáu en 2017" @default.
- Q37627010 description "bilimsel makale" @default.
- Q37627010 description "scientific article published on 02 February 2017" @default.
- Q37627010 description "vedecký článok" @default.
- Q37627010 description "vetenskaplig artikel" @default.
- Q37627010 description "videnskabelig artikel" @default.
- Q37627010 description "vědecký článek" @default.
- Q37627010 description "wetenschappelijk artikel" @default.
- Q37627010 description "wissenschaftlicher Artikel" @default.
- Q37627010 description "наукова стаття, опублікована в лютому 2017" @default.
- Q37627010 description "научни чланак" @default.
- Q37627010 description "مقالة علمية نشرت في 02 فبراير 2017" @default.
- Q37627010 name "Multi-Chemotherapeutic Schedules Containing the pan-FGFR Inhibitor ARQ 087 are Safe and Show Antitumor Activity in Different Xenograft Models" @default.
- Q37627010 name "Multi-Chemotherapeutic Schedules Containing the pan-FGFR Inhibitor ARQ 087 are Safe and Show Antitumor Activity in Different Xenograft Models" @default.
- Q37627010 name "Multi-Chemotherapeutic Schedules Containing the pan-FGFR Inhibitor ARQ 087 are Safe and Show Antitumor Activity in Different Xenograft Models" @default.
- Q37627010 type Item @default.
- Q37627010 label "Multi-Chemotherapeutic Schedules Containing the pan-FGFR Inhibitor ARQ 087 are Safe and Show Antitumor Activity in Different Xenograft Models" @default.
- Q37627010 label "Multi-Chemotherapeutic Schedules Containing the pan-FGFR Inhibitor ARQ 087 are Safe and Show Antitumor Activity in Different Xenograft Models" @default.
- Q37627010 label "Multi-Chemotherapeutic Schedules Containing the pan-FGFR Inhibitor ARQ 087 are Safe and Show Antitumor Activity in Different Xenograft Models" @default.
- Q37627010 prefLabel "Multi-Chemotherapeutic Schedules Containing the pan-FGFR Inhibitor ARQ 087 are Safe and Show Antitumor Activity in Different Xenograft Models" @default.
- Q37627010 prefLabel "Multi-Chemotherapeutic Schedules Containing the pan-FGFR Inhibitor ARQ 087 are Safe and Show Antitumor Activity in Different Xenograft Models" @default.
- Q37627010 prefLabel "Multi-Chemotherapeutic Schedules Containing the pan-FGFR Inhibitor ARQ 087 are Safe and Show Antitumor Activity in Different Xenograft Models" @default.
- Q37627010 P1433 Q37627010-49CE7A28-C5B6-43B0-A8CE-804FE43BD389 @default.
- Q37627010 P1476 Q37627010-76B8E74C-84B9-4140-AA9C-B803CCAFB216 @default.
- Q37627010 P2093 Q37627010-12D09709-40DF-446E-89F3-82447DD11A5B @default.
- Q37627010 P2093 Q37627010-284B7A46-40CA-4060-8946-AE962E57616E @default.
- Q37627010 P2093 Q37627010-549CAAA2-A858-4223-98DF-11557B11FB04 @default.
- Q37627010 P2093 Q37627010-976C68E8-78FA-40FB-8C08-2C844CDC8737 @default.
- Q37627010 P2093 Q37627010-C240CCAD-D832-4609-AD0D-3E9B6A96DC36 @default.
- Q37627010 P2860 Q37627010-106D2047-035E-4FEB-8414-00FFFDF85242 @default.
- Q37627010 P2860 Q37627010-11735131-3298-4612-A45C-59227F61C419 @default.
- Q37627010 P2860 Q37627010-18ECC87F-B104-4268-B1BB-084FADF752A1 @default.
- Q37627010 P2860 Q37627010-1DFB0C72-4F8E-49BC-BDAB-D950A5908BC3 @default.
- Q37627010 P2860 Q37627010-3EA4EDC0-4AAD-4977-B870-387AE1A98F75 @default.
- Q37627010 P2860 Q37627010-4DA752B8-0D13-4A26-A0BB-2606747A57E7 @default.
- Q37627010 P2860 Q37627010-4F8E6CC8-AF1B-4700-B36B-1C48B547B658 @default.
- Q37627010 P2860 Q37627010-534D9A41-BE83-4568-90A2-BEC7AE4F00E1 @default.
- Q37627010 P2860 Q37627010-6CB61725-73C0-4DAC-A2D7-F86A2203B5CF @default.
- Q37627010 P2860 Q37627010-6D2BC767-979D-4A18-A7D6-EDFEE846E555 @default.
- Q37627010 P2860 Q37627010-7A8A6F77-8B52-4A3D-9840-F5F158043684 @default.
- Q37627010 P2860 Q37627010-85F5C22F-692C-4A50-A1BE-E2E90547EDBB @default.
- Q37627010 P2860 Q37627010-92570F8C-CE0D-4A86-BCBA-5B0CE8722869 @default.
- Q37627010 P2860 Q37627010-9C3381A7-D526-4F91-8D03-ABD1DE026830 @default.
- Q37627010 P2860 Q37627010-A117C253-5ECF-4B83-AAAB-C7E4B7D3D52A @default.
- Q37627010 P2860 Q37627010-A11954D5-49D3-4F46-B4CD-C6EAEE90241F @default.
- Q37627010 P2860 Q37627010-A695E15B-A658-4205-94D7-5080C8361416 @default.
- Q37627010 P2860 Q37627010-BDEDE211-2717-4D08-A98D-C33FF4683A26 @default.
- Q37627010 P2860 Q37627010-C36BBC05-C0E9-4849-B092-1E2BB402C3D1 @default.
- Q37627010 P2860 Q37627010-CD205E18-377F-4952-BBA3-F347DCFAEA2D @default.
- Q37627010 P2860 Q37627010-CF7C7B4B-F7EB-49E6-A119-519D8F6DDA42 @default.
- Q37627010 P2860 Q37627010-ECCB35BD-B88B-459B-8867-4E8048669EC3 @default.
- Q37627010 P304 Q37627010-C46D4785-25AC-4B36-9950-CC70E5FC4F96 @default.
- Q37627010 P31 Q37627010-F838864E-D959-46C9-8755-262D4CEB96A7 @default.
- Q37627010 P356 Q37627010-D49504FE-2FF6-40CF-9A88-B02DA874097D @default.
- Q37627010 P407 Q37627010-8A5CD344-D57F-4B8E-8FD6-79A1FE33FCEE @default.
- Q37627010 P433 Q37627010-F7225202-50C7-45B5-BE8D-549A30CA2677 @default.
- Q37627010 P478 Q37627010-B1D49856-71F2-4469-96ED-790EB37FBFDD @default.
- Q37627010 P577 Q37627010-FA183DEA-6065-4E8C-848F-72A78690D6D9 @default.
- Q37627010 P698 Q37627010-A47B19B3-A8DA-477D-9CC1-6DBD49F4627B @default.
- Q37627010 P921 Q37627010-96CEC316-B26D-43BC-B666-48498CECDB1E @default.
- Q37627010 P921 Q37627010-A83F4360-D13E-4B44-A093-F388849A8642 @default.
- Q37627010 P932 Q37627010-27350572-2137-4C62-B404-CACB42B1BDCA @default.
- Q37627010 P356 J.TRANON.2016.12.003 @default.
- Q37627010 P698 28161661 @default.
- Q37627010 P1433 Q26839583 @default.
- Q37627010 P1476 "Multi-Chemotherapeutic Schedules Containing the pan-FGFR Inhibitor ARQ 087 are Safe and Show Antitumor Activity in Different Xenograft Models" @default.
- Q37627010 P2093 "Giovanna Damia" @default.
- Q37627010 P2093 "Giovanni Abbadessa" @default.
- Q37627010 P2093 "Massimo Broggini" @default.
- Q37627010 P2093 "Rosaria Chilà" @default.
- Q37627010 P2093 "Terence Hall G" @default.
- Q37627010 P2860 Q22252312 @default.
- Q37627010 P2860 Q26865765 @default.
- Q37627010 P2860 Q27322795 @default.
- Q37627010 P2860 Q27824766 @default.
- Q37627010 P2860 Q27860681 @default.
- Q37627010 P2860 Q29619277 @default.
- Q37627010 P2860 Q33967557 @default.
- Q37627010 P2860 Q34287101 @default.
- Q37627010 P2860 Q34375087 @default.
- Q37627010 P2860 Q34869530 @default.
- Q37627010 P2860 Q36554418 @default.
- Q37627010 P2860 Q36927558 @default.
- Q37627010 P2860 Q37002288 @default.
- Q37627010 P2860 Q38138234 @default.
- Q37627010 P2860 Q39220203 @default.
- Q37627010 P2860 Q39896267 @default.
- Q37627010 P2860 Q41345026 @default.
- Q37627010 P2860 Q46069528 @default.
- Q37627010 P2860 Q46597773 @default.
- Q37627010 P2860 Q46972019 @default.
- Q37627010 P2860 Q59566187 @default.
- Q37627010 P2860 Q70691552 @default.
- Q37627010 P304 "153-157" @default.
- Q37627010 P31 Q13442814 @default.
- Q37627010 P356 "10.1016/J.TRANON.2016.12.003" @default.